TY - JOUR
T1 - Imatinib (Gleevec®) as a paradigm of targeted cancer therapies
AU - Druker, Brian
PY - 2010/3
Y1 - 2010/3
KW - CML
KW - Imanitib
KW - Leukemia
KW - Molecularly targeted therapy
UR - http://www.scopus.com/inward/record.url?scp=77954302007&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954302007&partnerID=8YFLogxK
U2 - 10.2302/kjm.59.1
DO - 10.2302/kjm.59.1
M3 - Article
C2 - 20375651
AN - SCOPUS:77954302007
VL - 59
SP - 1
EP - 3
JO - Keio Journal of Medicine
JF - Keio Journal of Medicine
SN - 0022-9717
IS - 1
ER -